articleThe LancetOct 24, 2009Closed access

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

AAArne AstrupSRStephan RössnerLVLuc Van GaalARAila RissanenLNLeo Niskanen

University of Copenhagen · Karolinska University Hospital · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,154
total citations
FWCI
42.93
Percentile
100%
References
67
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Liraglutide
  • Orlistat
  • Medicine
  • Placebo
  • Tolerability
  • Weight loss
  • Clinical endpoint
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding